TIL Return on Tangible Equity | Instil Bio, Inc.

Instil Bio, Inc. (TIL) Return on Tangible Equity

2026-06-30: Return Tang Equity -28.20%.
2026-03-31: Return Tang Equity -42.80%.
2025-12-31: Return Tang Equity -62.68%.
2025-09-30: Return Tang Equity -62.34%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-28.20%
2026-03-31	-42.80%
2025-12-31	-62.68%
2025-09-30	-62.34%
2025-06-30	-64.18%
2025-03-31	-53.85%
2024-12-31	-43.75%
2024-09-30	-42.63%
2024-06-30	-61.32%
2024-03-31	-59.91%
2023-12-31	-69.12%
2023-09-30	-84.18%
2023-06-30	-62.66%
2023-03-31	-72.67%
2022-12-31	-61.38%
2022-09-30	-56.92%
2022-06-30	-47.79%
2022-03-31	-38.11%
2021-12-31	-29.07%
2021-09-30	-20.26%
2021-06-30	-13.38%
2021-03-31	-8.74%
2020-12-31	68.09%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-62.68%
2024-12-31	-43.75%
2023-12-31	-69.12%
2022-12-31	-61.38%
2021-12-31	-29.07%
2020-12-31	68.09%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Tevogen Inc. (TVGN)	United States	$0.049B
LeonaBio, Inc. (LONA)	United States	$0.047B	-0.61
Metagenomi Therapeutics, Inc. (MGX)	United States	$0.044B	-0.48
Scilex Holding Co (SCLX)	United States	$0.042B	-0.14
Inmune Bio, Inc. (INMB)	United States	$0.056B	-2.48
ImageneBio, Inc. (IMA)	United States	$0.056B	-1.31
BioAtla, Inc. (BCAB)	United States	$0.058B	-0.21
EXOZYMES INC. (EXOZ)	United States	$0.058B
MiNK Therapeutics, Inc. (INKT)	United States	$0.063B	-5.37
aTYR PHARMA INC (ATYR)	United States	$0.033B	-0.98